Further study revealed that IL-9–produced CD8+ T (Tc9) cells generated various cytokines and showed less cytolytic activity in vitro but surprisingly elicited enhanced antitumor responses against advanced tumors in OT-I/B16-OVA and Pmel-1/B16 melanoma models (170). The gene discussed is IL9; the disease is melanoma.